Back
10x Genomics 10K Form
Sell
22
TXG
10x Genomics
Last Price:
27.62
Seasonality Move:
-1.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TXG News And Ratings
See the #1 stock for the next 7 days that we like better than TXG
TXG Financial Statistics
Sales & Book Value
| Annual Sales: | $618.73M |
|---|---|
| Cash Flow: | $22.31M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.22 |
| Price / Book: | 4.44 |
Profitability
| EPS (TTM): | -2.17000 |
|---|---|
| Net Income (TTM): | $-255.1M |
| Gross Margin: | $409.31M |
| Return on Equity: | -32.81% |
| Return on Assets: | -25.79% |
10x Genomics Earnings Forecast
Key 10x Genomics Financial Ratios
- The Gross Profit Margin over the past 7 years for TXG is 66.15%.
- The Selling, General & Administrative Expenses for TXG have been equal to 55.49% of Gross Profit Margin.
- The Research & Development expenses have been 53.55% of Revenue.
- The Interest Expense is -0.01% of Operating Income.
- The Net Earning history of TXG is -41.23% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 2 years.
10x Genomics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | TXG |
| CUSIP: | 88025U |
| Website: | 10xgenomics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.69 |
| Quick Ratio: | 3.96 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TXG Technical Analysis vs Fundamental Analysis
Sell
22
10x Genomics (TXG)
is a Sell
Is 10x Genomics a Buy or a Sell?
-
10x Genomics stock is rated a Sell
The current 10x Genomics [TXG] share price is $27.59. The Score for TXG is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.